-
3 weeks ago | 
glaucomaphysician.net | Karen Appold
Inder Paul Singh, MD, a glaucoma surgeon and the president of The Eye Centers of Racine and Kenosha in Wisconsin, was eager to try Alcon’s new Voyager Direct Selective Laser Trabeculoplasty (DSLT) system at his practice, because data indicate that SLT is a better first-line treatment for most glaucoma patients than topical drops. He maintains that DSLT is a win-win for patients and physicians. “SLT can’t be used on some patients who have angles that are difficult to view,” he says.
-
2 months ago | 
everydayhealth.com | Karen Appold
Crohn's DiseaseExplore This TopicShareCrohn's DiseaseLearn about managing Crohn's disease with expert tips on diet, treatments, and lifestyle changes to help reduce flare-ups and improve gut health. LEARN MORE1What Is Crohn’s Disease?
-
2 months ago | 
the-hospitalist.org | Karen Appold |Ronda Whitaker
Every incentive counts when it comes to recruiting and retaining top talent. In particular, today’s hospitalists view funding for continuing medical education (CME) and getting paid time off (PTO) as some of the most important benefits.
-
Mar 1, 2025 | 
retinalphysician.com | Karen Appold
Zeiss Medical Technology’s newest optical coherence tomography (OCT) device, the Cirrus 6000, provides an efficient and data-driven workflow for ophthalmologists, supported by the largest OCT reference database in the US market, as well as newly enhanced cybersecurity features, says Anuj Kalra, head of the business sector for chronic disease management at Carl Zeiss Meditec in Dublin, California.
-
Jan 8, 2025 | 
enttoday.org | Karen Appold
Residents are constantly developing and refining their technical and cognitive skills. “But without structured, actionable feedback from mentors, residents can have difficulty knowing what specific adjustments are needed to improve,” said Jenny X. Chen, MD, EdM, assistant professor in the department of otolaryngology–head and neck surgery at Johns Hopkins School of Medicine in Baltimore.
-
Nov 1, 2024 | 
the-hospitalist.org | Karen Appold |Ronda Whitaker
Inhonor of Veterans Day, The Hospitalist asked SHM members who work for the Veterans Health Administration (VHA) to share their insights on working for the largest integrated healthcare system in the U.S.Overwhelmingly, hospitalists cited as the greatest benefit the privilege to provide care to those who served our country. They also touted many other perks, such as research and educational opportunities, and excellent benefits.
-
Sep 6, 2024 | 
enttoday.org | Karen Appold
The Triological Society has awarded more than $7 million to otolaryngologists to support their clinical and basic research through two competitive research grant programs since 2000. The Triological Society Research Career Development Awards provide funding to otolaryngologists for their research projects at an early faculty stage, before they have received funding from the National Institutes of Health (NIH).
-
Sep 3, 2024 | 
the-hospitalist.org | Karen Appold |Ronda Whitaker
Healthcare practitioners have firsthand knowledge about the strengths and weaknesses of the current healthcare environment.
-
Aug 31, 2024 | 
glaucomaphysician.net | Karen Appold
Glaukos’s iStent infinite Trabecular Micro-Bypass System is the first FDA-cleared microinvasive implantable device that can be used in combination with cataract surgery or as a standalone treatment option for glaucoma patients not undergoing concomitant cataract surgery.
-
Aug 31, 2024 | 
retinalphysician.com | Karen Appold
Monitoring retinal diseases with a high incidence of recurrence, such as neovascular (or “wet”) age-related macular degeneration (nAMD), can be very difficult. A new optical coherence tomography (OCT) scanning device that allows patients to be monitored outside the office could help to alleviate this challenge. In May, the US Food and Drug Administration (FDA) granted de novo marketing authorization to Notal Vision’s artificial intelligence (AI)–powered Scanly Home OCT device.
